Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare, usually aggressive, primary thymic carcinoma, characterized by the presence of carcinoma cells with clear cytoplasm.
Biomarker and diagnostic research for thymus clear cell carcinoma has been reported in the published literature.
No clinical trials have been registered for thymus clear cell carcinoma.
6 publications have been identified in PubMed for thymus clear cell carcinoma. Research spans Review / Meta-Analysis (33%), Case Report / Case Series (33%), and Diagnostic / Biomarker (17%).
Zeng Y (2026). [PMID: 41066478](https://pubmed.ncbi.nlm.nih.gov/41066478/). *International journal of surgical pathology*. [Review / Meta-Analysis]
Sonobe H (2026). [PMID: 41196319](https://pubmed.ncbi.nlm.nih.gov/41196319/). *Medical molecular morphology*. [Case Report / Case Series]
Hwang J (2025). [PMID: 39773530](https://pubmed.ncbi.nlm.nih.gov/39773530/). *JCI insight*. [Diagnostic / Biomarker]
Maluf H (2025). [PMID: 38199878](https://pubmed.ncbi.nlm.nih.gov/38199878/). *Seminars in diagnostic pathology*. [Review / Meta-Analysis]
Wang YN (2024). [PMID: 39473963](https://pubmed.ncbi.nlm.nih.gov/39473963/). *World journal of gastrointestinal oncology*. [Basic Science / Preclinical]
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 7:51 PM UTC
Monroe HL (2024). [PMID: 37461831](https://pubmed.ncbi.nlm.nih.gov/37461831/). *International journal of surgical pathology*. [Case Report / Case Series]